Skip to content

Clinical trials

Phase 3 Major Depressive Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Phase: Phase 3 Clear all

388 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20016
200216
20039
200416
200521
200627
200713
200815
200918
201024
201129
201218
201313
201414
201512
201610
20176
201816
201910
202012
202110
20229
20238
202412
202519
202616

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed289
Recruiting31
Terminated30
Withdrawn13
Not yet recruiting8
Unknown status7
Active, not recruiting7
Suspended2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company21
H. Lundbeck A/S21
Forest Laboratories18
Otsuka Pharmaceutical Development & Commercialization, Inc.18
Wyeth is now a wholly owned subsidiary of Pfizer18
AstraZeneca14
Janssen Research & Development, LLC13
Takeda13
Sanofi11
Naurex, Inc, an affiliate of Allergan plc10

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder388
Depressive Disorder35
Mood Disorders13
Depressive Disorder, Treatment-Resistant12
Mental Disorders12
Bipolar Disorder11
Psychotic Disorders11
Sleep Initiation and Maintenance Disorders8
Anxiety Disorders6
Schizophrenia5

Trials

Showing 26 to 50 of 388. Each trial links to its page on Pharma Observatory.

288 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.